Raymond James Financial Services Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,150
Closed -$283K 3351
2022
Q3
$283K Sell
1,150
-232
-17% -$57.1K ﹤0.01% 2601
2022
Q2
$342K Buy
1,382
+211
+18% +$52.2K ﹤0.01% 2495
2022
Q1
$388K Sell
1,171
-16,961
-94% -$5.62M ﹤0.01% 2523
2021
Q4
$6.51M Buy
18,132
+592
+3% +$213K 0.01% 885
2021
Q3
$5.71M Buy
17,540
+9,444
+117% +$3.07M 0.01% 900
2021
Q2
$2.53M Buy
8,096
+467
+6% +$146K 0.01% 1343
2021
Q1
$2.43M Buy
7,629
+1,127
+17% +$359K 0.01% 1276
2020
Q4
$2.11M Sell
6,502
-14,199
-69% -$4.6M 0.01% 1263
2020
Q3
$5.74M Buy
20,701
+14,820
+252% +$4.11M 0.02% 703
2020
Q2
$1.42M Buy
5,881
+1,061
+22% +$256K ﹤0.01% 1286
2020
Q1
$700K Buy
4,820
+721
+18% +$105K ﹤0.01% 1372
2019
Q4
$699K Sell
4,099
-806
-16% -$137K ﹤0.01% 1763
2019
Q3
$873K Sell
4,905
-859
-15% -$153K ﹤0.01% 1540
2019
Q2
$1.5M Sell
5,764
-2,876
-33% -$749K 0.01% 1258
2019
Q1
$2.47M Buy
8,640
+2,832
+49% +$809K 0.01% 963
2018
Q4
$1.89M Sell
5,808
-2,499
-30% -$812K 0.01% 930
2018
Q3
$3.74M Sell
8,307
-5,252
-39% -$2.36M 0.02% 763
2018
Q2
$5.55M Buy
13,559
+3,347
+33% +$1.37M 0.03% 564
2018
Q1
$2.97M Buy
10,212
+6,617
+184% +$1.93M 0.02% 765
2017
Q4
$674K Buy
3,595
+1,682
+88% +$315K ﹤0.01% 1535
2017
Q3
$323K Sell
1,913
-147
-7% -$24.8K ﹤0.01% 1979
2017
Q2
$295K Sell
2,060
-780
-27% -$112K ﹤0.01% 1996
2017
Q1
$356K Sell
2,840
-945
-25% -$118K ﹤0.01% 1793
2016
Q4
$426K Sell
3,785
-9,072
-71% -$1.02M ﹤0.01% 1615
2016
Q3
$1.65M Sell
12,857
-15,605
-55% -$2.01M 0.01% 846
2016
Q2
$3.11M Sell
28,462
-4,079
-13% -$446K 0.03% 549
2016
Q1
$3.09M Buy
+32,541
New +$3.09M 0.04% 466